4,526
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Antibody–drug conjugates for previously treated aggressive lymphomas: focus on polatuzumab vedotin

, , , &
Pages 1073-1083 | Received 03 Jul 2020, Accepted 17 Sep 2020, Published online: 05 Oct 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.